Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian E Gawronski

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|April 10, 2024
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experimentBrian E Gawronski, Ramzi G Salloum, Julio D Duarte
Circulation. Genomic and Precision Medicine|May 20, 2024
Using Omics to Identify Novel Therapeutic Targets in Heart FailureChristelle Lteif, Yimei Huang, Leonardo A Guerra, et al.
Pharmacogenomics|April 11, 2025
Implementation of clinical pharmacogenetic testing in medically underserved patients: a narrative reviewBrian E Gawronski, Irina Fofanova, Angel M Miranda, et al.
Frontiers in Genetics|January 30, 2023
Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underservedBrian E Gawronski, Emily J Cicali, Caitrin W McDonough, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activationHao-Jie Zhu, Xinwen Wang, Brian E Gawronski, et al.
Frontiers in Cardiovascular Medicine|March 10, 2025
Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient populationLeonardo A Guerra, Christelle Lteif, Yimei Huang, et al.
Journal of Personalized Medicine|December 27, 2024
Enhancing the Integration of Pre-Emptive Pharmacogenetic (PGx) Testing in Primary Care: Prioritizing Underserved Patients' Preferences in ImplementationEmma G Bryan, Kelsey Lunsford, Michaela D Mullis, et al.
Clinical and Translational Science|April 25, 2025
Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing PanelChristelle Lteif, Brian E Gawronski, Emily J Cicali, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 2012
CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human liversDanxin Wang, Xiaochun Sun, Yan Gong, et al.
Journal of Cardiology|August 31, 2014
Floppy mitral valve/mitral valve prolapse syndrome: Beta-adrenergic receptor polymorphism may contribute to the pathogenesis of symptomsEfstratios K Theofilogiannakos, Konstantinos Dean Boudoulas, Brian E Gawronski, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|April 10, 2024
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experimentBrian E Gawronski, Ramzi G Salloum, Julio D Duarte
Circulation. Genomic and Precision Medicine|May 20, 2024
Using Omics to Identify Novel Therapeutic Targets in Heart FailureChristelle Lteif, Yimei Huang, Leonardo A Guerra, et al.
Pharmacogenomics|April 11, 2025
Implementation of clinical pharmacogenetic testing in medically underserved patients: a narrative reviewBrian E Gawronski, Irina Fofanova, Angel M Miranda, et al.
Frontiers in Genetics|January 30, 2023
Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underservedBrian E Gawronski, Emily J Cicali, Caitrin W McDonough, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activationHao-Jie Zhu, Xinwen Wang, Brian E Gawronski, et al.
Frontiers in Cardiovascular Medicine|March 10, 2025
Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient populationLeonardo A Guerra, Christelle Lteif, Yimei Huang, et al.
Journal of Personalized Medicine|December 27, 2024
Enhancing the Integration of Pre-Emptive Pharmacogenetic (PGx) Testing in Primary Care: Prioritizing Underserved Patients' Preferences in ImplementationEmma G Bryan, Kelsey Lunsford, Michaela D Mullis, et al.
Clinical and Translational Science|April 25, 2025
Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing PanelChristelle Lteif, Brian E Gawronski, Emily J Cicali, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 2012
CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human liversDanxin Wang, Xiaochun Sun, Yan Gong, et al.
Journal of Cardiology|August 31, 2014
Floppy mitral valve/mitral valve prolapse syndrome: Beta-adrenergic receptor polymorphism may contribute to the pathogenesis of symptomsEfstratios K Theofilogiannakos, Konstantinos Dean Boudoulas, Brian E Gawronski, et al.
Pageof 2